Results 151 to 160 of about 64,427 (282)

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome–positive chronic phase chronic myeloid leukemia [PDF]

open access: bronze, 2003
Hagop M. Kantarjian   +12 more
openalex   +1 more source

A rare complication of imatinib mesylate therapy: drug-induced pneumonitis

open access: yesТерапевтический архив, 2010
The use of imatinib mesylate (Glivec®) (Novartis Pharma AG, Switzerland) that is the drug of choice in treating patients with chronic myeloid leukemia (CML) has increased 7-year survival and improved the prognosis of the disease.
Ol'ga Veniaminovna Stakhina   +7 more
doaj  

Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis [PDF]

open access: bronze, 2004
Craig Daniels   +6 more
openalex   +2 more sources

Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome [PDF]

open access: bronze, 2003
Jorge E. Cortés   +9 more
openalex   +1 more source

Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells. [PDF]

open access: yesGels, 2022
Khaing EM   +5 more
europepmc   +1 more source

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571) [PDF]

open access: bronze, 2003
Lara Wohlbold   +6 more
openalex   +1 more source

Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta [PDF]

open access: bronze, 2003
Juan Luis Garcı́a   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy